Related Experiment Video

Updated: Jun 27, 2026

Creation of Reversible Cholestatic Rat Model
09:39

Creation of Reversible Cholestatic Rat Model

Published on: May 21, 2011

Renal elimination of organic anions in cholestasis

Adriana Monica Torres

    World Journal of Gastroenterology
    |November 27, 2008
    PubMed

    Insights

    Cholestasis impacts kidney function and drug elimination by altering organic anion transporters (OAT1 and OAT3). Understanding these changes is crucial for effective drug therapy and preventing toxicity during liver disease.

    Area of Science:

    • Pharmacology
    • Nephrology
    • Hepatology

    Background:

    • Drug disposition relies on specialized transporters, including organic anion transporters (OAT1 and OAT3) in renal proximal tubules.
    • OAT1 and OAT3 are vital for secreting xenobiotics and endogenous organic anions, influencing drug elimination.
    • Cholestasis, a liver condition, can lead to kidney damage and alter drug metabolism and excretion.

    Discussion:

    • Extrahepatic cholestasis significantly affects the renal abundance of OAT1 and OAT3.
    • The time course of obstructive cholestasis influences the regulation of these key organic anion transporters.
    • Renal OAT1 and OAT3 expression is a critical factor in drug elimination during cholestasis.

    Key Insights:

    • Impaired kidney function due to cholestasis modifies the renal elimination pathways for many drugs.
    • The expression levels of OAT1 and OAT3 are directly linked to the renal clearance of organic anions in cholestatic conditions.
    • Changes in OAT1 and OAT3 are central to understanding altered pharmacokinetics during cholestasis.

    Outlook:

    • Monitoring renal OAT1 and OAT3 expression can optimize pharmacotherapeutic strategies.
    • Adjusting drug dosages based on transporter status may prevent toxicity in patients with cholestasis.
    • Further research into transporter regulation during cholestasis will enhance drug safety and efficacy.

    More Related Videos

    Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport08:42

    Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

    Published on: November 27, 2016

    Related Concept Videos

    Drug Elimination by Renal Route: Tubular Reabsorption01:22

    Drug Elimination by Renal Route: Tubular Reabsorption

    During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
    Enhanced Elimination of Poison01:26

    Enhanced Elimination of Poison

    Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
    Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
    Renal excretion is the...
    Drug Elimination: Non-Renal Routes01:23

    Drug Elimination: Non-Renal Routes

    The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
    Hepatic Drug Excretion: Influencing Factors01:16

    Hepatic Drug Excretion: Influencing Factors

    The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
    Hepatic Drug Excretion: Enterohepatic Cycling01:17

    Hepatic Drug Excretion: Enterohepatic Cycling

    Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
    Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
    Renal Drug Excretion: Tubular Reabsorption01:25

    Renal Drug Excretion: Tubular Reabsorption

    Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...